Hologic clears regulatory hurdle in Canada for 2 HPV assays

04/8/2013 | GenomeWeb Daily News (free registration)

Hologic has obtained approval to market its Aptima HPV and Aptima HPV 16 18/45 tests in Canada. The genotype assays, which already have been approved by the FDA, work with the company's Tigris technology and are used to identify human papillomavirus strains that are linked to precancerous lesions and cervical cancer.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel
Cardinal Health
Columbus, OH
Regulatory Affairs Specialist
Stryker
Mahwah, NJ
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA